Guaifenesin and Dextromethorphan Hydrobromide

Product NDC: 51660-073
Requested package NDC: 51660-073-86
11-digit product format: 516600073
Labeler code: 51660
Product ID: 51660-073_62d9d841-9307-45a7-89a7-cba5cded1462
Type: HUMAN OTC DRUG
Nonproprietary name: Guaifenesin and Dextromethorphan Hydrobromide
Dosage form: TABLET, EXTENDED RELEASE
Route: ORAL
Labeler: OHM LABORATORIES INC
Application: NDA021620
Marketing category: NDA
Marketing start: 2017-12-10
Marketing end: 0000-00-00
Substance: GUAIFENESIN; DEXTROMETHORPHAN HYDROBROMIDE
Active strength: 1200 mg/1; mg/1
NDC exclude flag: No
Listing certified through: 2020-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	51660-073	51660-073-86	I	Inactivated by FDA		2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 15 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source date	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	`1332a3947898…`	`d4bfe170f9cd…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N021620-001	MUCINEX DM	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	60MG;1.2GM	TABLET, EXTENDED RELEASE / ORAL		RLD, RS	2004-04-29
N021620-002	MUCINEX DM	DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN	30MG;600MG	TABLET, EXTENDED RELEASE / ORAL		RLD	2004-04-29

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 84 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	N021620-001	MUCINEX DM	60MG;1.2GM	TABLET, EXTENDED RELEASE / ORAL	RLD, RS	2004-04-29	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021620-002	MUCINEX DM	30MG;600MG	TABLET, EXTENDED RELEASE / ORAL	RLD	2004-04-29	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N021620-001	MUCINEX DM	60MG;1.2GM	TABLET, EXTENDED RELEASE / ORAL	RLD, RS	2004-04-29	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021620-002	MUCINEX DM	30MG;600MG	TABLET, EXTENDED RELEASE / ORAL	RLD	2004-04-29	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021620-001	MUCINEX DM	60MG;1.2GM	TABLET, EXTENDED RELEASE / ORAL	RLD, RS	2004-04-29	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021620-002	MUCINEX DM	30MG;600MG	TABLET, EXTENDED RELEASE / ORAL	RLD	2004-04-29	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N021620-001	MUCINEX DM	60MG;1.2GM	TABLET, EXTENDED RELEASE / ORAL	RLD, RS	2004-04-29	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021620-002	MUCINEX DM	30MG;600MG	TABLET, EXTENDED RELEASE / ORAL	RLD	2004-04-29	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021620-001	MUCINEX DM	60MG;1.2GM	TABLET, EXTENDED RELEASE / ORAL	RLD, RS	2004-04-29	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021620-002	MUCINEX DM	30MG;600MG	TABLET, EXTENDED RELEASE / ORAL	RLD	2004-04-29	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021620-001	MUCINEX DM	60MG;1.2GM	TABLET, EXTENDED RELEASE / ORAL	RLD, RS	2004-04-29	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021620-002	MUCINEX DM	30MG;600MG	TABLET, EXTENDED RELEASE / ORAL	RLD	2004-04-29	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021620-001	MUCINEX DM	60MG;1.2GM	TABLET, EXTENDED RELEASE / ORAL	RLD, RS	2004-04-29	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021620-002	MUCINEX DM	30MG;600MG	TABLET, EXTENDED RELEASE / ORAL	RLD	2004-04-29	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021620-001	MUCINEX DM	60MG;1.2GM	TABLET, EXTENDED RELEASE / ORAL	RLD, RS	2004-04-29	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021620-002	MUCINEX DM	30MG;600MG	TABLET, EXTENDED RELEASE / ORAL	RLD	2004-04-29	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021620-001	MUCINEX DM	60MG;1.2GM	TABLET, EXTENDED RELEASE / ORAL	RLD, RS	2004-04-29	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021620-002	MUCINEX DM	30MG;600MG	TABLET, EXTENDED RELEASE / ORAL	RLD	2004-04-29	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021620-001	MUCINEX DM	60MG;1.2GM	TABLET, EXTENDED RELEASE / ORAL	RLD, RS	2004-04-29	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021620-002	MUCINEX DM	30MG;600MG	TABLET, EXTENDED RELEASE / ORAL	RLD	2004-04-29	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N021620-001	MUCINEX DM	60MG;1.2GM	TABLET, EXTENDED RELEASE / ORAL	RLD, RS	2004-04-29	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N021620-002	MUCINEX DM	30MG;600MG	TABLET, EXTENDED RELEASE / ORAL	RLD	2004-04-29	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021620-001	MUCINEX DM	60MG;1.2GM	TABLET, EXTENDED RELEASE / ORAL	RLD, RS	2004-04-29	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021620-002	MUCINEX DM	30MG;600MG	TABLET, EXTENDED RELEASE / ORAL	RLD	2004-04-29	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021620-001	MUCINEX DM	60MG;1.2GM	TABLET, EXTENDED RELEASE / ORAL	RLD, RS	2004-04-29	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021620-002	MUCINEX DM	30MG;600MG	TABLET, EXTENDED RELEASE / ORAL	RLD	2004-04-29	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021620-001	MUCINEX DM	60MG;1.2GM	TABLET, EXTENDED RELEASE / ORAL	RLD, RS	2004-04-29	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021620-002	MUCINEX DM	30MG;600MG	TABLET, EXTENDED RELEASE / ORAL	RLD	2004-04-29	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N021620-001	MUCINEX DM	60MG;1.2GM	TABLET, EXTENDED RELEASE / ORAL	RLD, RS	2004-04-29	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N021620-002	MUCINEX DM	30MG;600MG	TABLET, EXTENDED RELEASE / ORAL	RLD	2004-04-29	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N021620-001	MUCINEX DM	60MG;1.2GM	TABLET, EXTENDED RELEASE / ORAL	RLD, RS	2004-04-29	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N021620-002	MUCINEX DM	30MG;600MG	TABLET, EXTENDED RELEASE / ORAL	RLD	2004-04-29	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N021620-001	MUCINEX DM	60MG;1.2GM	TABLET, EXTENDED RELEASE / ORAL	RLD, RS	2004-04-29	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N021620-002	MUCINEX DM	30MG;600MG	TABLET, EXTENDED RELEASE / ORAL	RLD	2004-04-29	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N021620-001	MUCINEX DM	60MG;1.2GM	TABLET, EXTENDED RELEASE / ORAL	RLD, RS	2004-04-29	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N021620-002	MUCINEX DM	30MG;600MG	TABLET, EXTENDED RELEASE / ORAL	RLD	2004-04-29	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N021620-001	MUCINEX DM	60MG;1.2GM	TABLET, EXTENDED RELEASE / ORAL	RLD, RS	2004-04-29	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021620-002	MUCINEX DM	30MG;600MG	TABLET, EXTENDED RELEASE / ORAL	RLD	2004-04-29	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N021620-001	MUCINEX DM	60MG;1.2GM	TABLET, EXTENDED RELEASE / ORAL	RLD, RS	2004-04-29	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	N021620-002	MUCINEX DM	30MG;600MG	TABLET, EXTENDED RELEASE / ORAL	RLD	2004-04-29	`bb7c543d1eb4…`

Observed Orange Book patent history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Submission date	Source SHA-256
2019-12-13 00:20 UTC	2019-12	N021620-001	6372252	2020-04-28		Drug product		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021620-001	6955821	2020-04-28	U-685	Drug product		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021620-001	7838032	2020-04-28		Drug product	2010-12-21	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021620-002	6372252	2020-04-28		Drug product		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021620-002	6955821	2020-04-28	U-685	Drug product		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021620-002	7838032	2020-04-28		Drug product		`74a2ff9319b5…`
2020-12-22 03:56 UTC	2020-12	N021620-001	6372252	2020-04-28		Drug product		`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N021620-001	6955821	2020-04-28	U-685	Drug product		`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N021620-001	7838032	2020-04-28		Drug product	2010-12-21	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N021620-002	6372252	2020-04-28		Drug product		`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N021620-002	6955821	2020-04-28	U-685	Drug product		`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N021620-002	7838032	2020-04-28		Drug product		`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N021620-001	6372252	2020-04-28		Drug product		`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N021620-001	6955821	2020-04-28	U-685	Drug product		`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N021620-001	7838032	2020-04-28		Drug product	2010-12-21	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N021620-002	6372252	2020-04-28		Drug product		`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N021620-002	6955821	2020-04-28	U-685	Drug product		`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N021620-002	7838032	2020-04-28		Drug product		`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N021620-001	6372252	2020-04-28		Drug product		`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N021620-001	6955821	2020-04-28	U-685	Drug product		`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N021620-001	7838032	2020-04-28		Drug product	2010-12-21	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N021620-002	6372252	2020-04-28		Drug product		`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N021620-002	6955821	2020-04-28	U-685	Drug product		`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N021620-002	7838032	2020-04-28		Drug product		`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N021620-001	6372252	2020-04-28		Drug product		`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N021620-001	6955821	2020-04-28	U-685	Drug product		`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N021620-001	7838032	2020-04-28		Drug product	2010-12-21	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N021620-002	6372252	2020-04-28		Drug product		`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N021620-002	6955821	2020-04-28	U-685	Drug product		`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N021620-002	7838032	2020-04-28		Drug product		`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N021620-001	6372252	2020-04-28		Drug product		`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N021620-001	6955821	2020-04-28	U-685	Drug product		`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N021620-001	7838032	2020-04-28		Drug product	2010-12-21	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N021620-002	6372252	2020-04-28		Drug product		`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N021620-002	6955821	2020-04-28	U-685	Drug product		`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N021620-002	7838032	2020-04-28		Drug product		`ea99ee380514…`

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
51660-073-54	2024-01-30	C162847	48780-1	1030e365-614d-111a-e063-dadaa90a10e2	Guaifenesin 1200 mg Extended-Release Tablets & Dextromethorphan HBr 60 mg
51660-073-86	2024-01-30	C162847	48780-1	1030e365-614d-111a-e063-dadaa90a10e2	Guaifenesin 1200 mg Extended-Release Tablets & Dextromethorphan HBr 60 mg

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
51660-073-54	Guaifenesin and Dextromethorphan Hydrobromide	14 in 1 BLISTER PACK	TABLET, EXTENDED RELEASE	14	3
51660-073-54	Guaifenesin and Dextromethorphan Hydrobromide	1 in 1 CARTON	TABLET, EXTENDED RELEASE	1	3
51660-073-86	Guaifenesin and Dextromethorphan Hydrobromide	2 in 1 CARTON	TABLET, EXTENDED RELEASE	2	3
51660-073-86	Guaifenesin and Dextromethorphan Hydrobromide	14 in 1 BLISTER PACK	TABLET, EXTENDED RELEASE	14	3

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
51660-073-54	EA - Each	51660-073	6e964448-c4fb-436c-9650-fb58e3d2d81d	1	2019-03-12
51660-073-86	EA - Each	51660-073	7dc7f87e-a60b-42bb-8e2c-e4e1721a2037	1	2019-03-12

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
51660-073	GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE TABLET, EXTENDED RELEASE [OHM LABORATORIES INC]	3	Legacy NDC, 4 package rows	20181102_ed496cde-4355-45c4-80f0-84df06c32523.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 9 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Mucinex DM	GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE	Reckitt Benckiser LLC	70987d06-d206-445f-bd0d-5e1345b8465c	2026-06-15	Warnings	Exact identifier application applno (NDA): 021620 application number: NDA021620
Mucinex DM Maximum Strength	GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE	Reckitt Benckiser LLC	588eddc1-fa30-41cc-8ed9-c01319ea21c6	2026-05-27	Warnings	Exact identifier application applno (NDA): 021620 application number: NDA021620
Mucinex DM	GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE	A-S Medication Solutions	c04e67da-51f6-4ce3-9852-419d7b3a3742	2026-05-22	Warnings	Exact identifier application applno (NDA): 021620 application number: NDA021620
Mucinex DM	GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE	Sportpharm LLC	8f4af6dd-6df4-49a7-98cf-655136923734	2026-02-26	Warnings	Exact identifier application applno (NDA): 021620 application number: NDA021620
Mucinex DM	GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE	Select Consumer Group	3c9c8fb0-8a00-4b0f-e063-6394a90af632	2025-12-28	Warnings	Exact identifier application applno (NDA): 021620 application number: NDA021620
MUCINEX DM	GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE	A-S Medication Solutions	fcaf1df9-b396-44f2-94ce-e46e80aba66c	2025-10-01	Warnings	Exact identifier application applno (NDA): 021620 application number: NDA021620
Mucinex DM, TRAVEL BASIX	GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE	Lil' Drug Store Products, Inc.	c274b05c-8f05-4980-9a93-77affb322e57	2023-10-10	Warnings	Exact identifier application applno (NDA): 021620 application number: NDA021620
Mucinex DM Maximum Strength	GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE	A-S Medication Solutions	104b29ed-a377-4436-8e24-413c63579f2e	2023-07-27	Warnings	Exact identifier application applno (NDA): 021620 application number: NDA021620
Mucinex DM	DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN	Navajo Manufacturing Company Inc.	4226f394-f85e-45b1-8d5f-7cffb7dd492f	2023-03-16	Warnings	Exact identifier application applno (NDA): 021620 application number: NDA021620

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
495W7451VQ	GUAIFENESIN	93-14-1	GUAIFENESIN
9D2RTI9KYH	DEXTROMETHORPHAN HYDROBROMIDE	6700-34-1	DEXTROMETHORPHAN HYDROBROMIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1099074	guaiFENesin 1200 MG / dextromethorphan HBr 60 MG 12HR Extended Release Oral Tablet	PSN	ed496cde-4355-45c4-80f0-84df06c32523	3
1099074	12 HR dextromethorphan hydrobromide 60 MG / guaifenesin 1200 MG Extended Release Oral Tablet	SCD	ed496cde-4355-45c4-80f0-84df06c32523	3
1099074	dextromethorphan hydrobromide 60 MG / guaifenesin 1200 MG 12 HR Extended Release Oral Tablet	SY	ed496cde-4355-45c4-80f0-84df06c32523	3

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
51660-073-86	51660007386	2 BLISTER PACK in 1 CARTON (51660-073-86) > 14 TABLET, EXTENDED RELEASE in 1 BLISTER PACK	2 blister pack	2017-12-10	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Guaifenesin 1200 mg Extended-Release Tablets & Dextromethorphan HBr 60 mg	OHM LABORATORIES INC \| RECKITT BENCKISER HEALTHCARE INTERNATIONAL LTD	2018-10-30	HUMAN OTC DRUG LABEL	3